{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T12:47:26Z","timestamp":1785934046489,"version":"3.56.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Kermanshah University of Medical Sciences Research Council","award":["4020771"],"award-info":[{"award-number":["4020771"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-44924-4","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T13:36:24Z","timestamp":1779802584000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Discovering novel multi-target compounds against aspartyl viral polymerases via ligand-based pharmacophore and structure-based screening"],"prefix":"10.1038","volume":"16","author":[{"given":"Armin","family":"Zarei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Ezati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc T.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Schenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi","family":"Adibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"44924_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s44298-024-00017-5","volume":"2","author":"JTS Chu","year":"2024","unstructured":"Chu, J. T. S. & Lamers, M. M. Organoids in virology. npj Viruses 2, 5 (2024).","journal-title":"npj Viruses"},{"key":"44924_CR2","doi-asserted-by":"publisher","first-page":"17006","DOI":"10.1038\/nrdp.2017.6","volume":"3","author":"MP Manns","year":"2017","unstructured":"Manns, M. P. et al. Hepatitis C virus infection. Nat. Rev. Dis. Primers. 3, 17006 (2017).","journal-title":"Nat. Rev. Dis. Primers."},{"key":"44924_CR3","unstructured":"WHO. Hepatitis C, <https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c> ((2021))."},{"key":"44924_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cells8040317","volume":"8","author":"JL Casey","year":"2019","unstructured":"Casey, J. L., Feld, J. J. & MacParland, S. A. Restoration of HCV-specific immune responses with antiviral therapy: A case for DAA treatment in acute HCV infection. Cells 8, 317 (2019).","journal-title":"Cells"},{"key":"44924_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-023-00452-3","volume":"9","author":"L-G Bekker","year":"2023","unstructured":"Bekker, L.-G. et al. HIV infection. Nat. Rev. Dis. Primers. 9, 42 (2023).","journal-title":"Nat. Rev. Dis. Primers."},{"key":"44924_CR6","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S0140-6736(20)30185-9","volume":"395","author":"C Wang","year":"2020","unstructured":"Wang, C., Horby, P. W., Hayden, F. G. & Gao, G. F. A novel coronavirus outbreak of global health concern. The lancet 395, 470\u2013473 (2020).","journal-title":"The lancet"},{"key":"44924_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46296-7","volume":"15","author":"D Lee","year":"2024","unstructured":"Lee, D. et al. Bioengineered amyloid peptide for rapid screening of inhibitors against main protease of SARS-CoV-2. Nat. Commun. 15, 2108 (2024).","journal-title":"Nat. Commun."},{"key":"44924_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29513-z","volume":"13","author":"V-T Tran","year":"2022","unstructured":"Tran, V.-T., Porcher, R., Pane, I. & Ravaud, P. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nat. Commun. 13, 1812 (2022).","journal-title":"Nat. Commun."},{"key":"44924_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20053-y","volume":"11","author":"B Mizrahi","year":"2020","unstructured":"Mizrahi, B. et al. Longitudinal symptom dynamics of COVID-19 infection. Nat. Commun. 11, 6208 (2020).","journal-title":"Nat. Commun."},{"key":"44924_CR10","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/s41586-022-05664-3","volume":"614","author":"BF Malone","year":"2023","unstructured":"Malone, B. F. et al. Structural basis for substrate selection by the SARS-CoV-2 replicase. Nature 614, 781\u2013787 (2023).","journal-title":"Nature"},{"key":"44924_CR11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1021\/acs.jnatprod.0c00968","volume":"84","author":"MP Christy","year":"2021","unstructured":"Christy, M. P., Uekusa, Y., Gerwick, L. & Gerwick, W. H. Natural products with potential to treat RNA virus pathogens including SARS-CoV-2. J. Nat. Prod. 84, 161\u2013182 (2021).","journal-title":"J. Nat. Prod."},{"key":"44924_CR12","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1126\/science.abb7498","volume":"368","author":"Y Gao","year":"2020","unstructured":"Gao, Y. et al. Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science 368, 779\u2013782 (2020).","journal-title":"Science"},{"key":"44924_CR13","first-page":"1084","volume":"2","author":"J Aranda","year":"2022","unstructured":"Aranda, J., Wiecz\u00f3r, M., Terrazas, M., Brun-Heath, I. & Orozco, M. Mechanism of reaction of RNA-dependent RNA polymerase from SARS-CoV-2. Chem. Catal. 2, 1084\u20131099 (2022).","journal-title":"Chem. Catal."},{"key":"44924_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2023.123153","volume":"390","author":"M Ansari","year":"2023","unstructured":"Ansari, M. et al. Computational investigation on the potential inhibitory effect of fungal metabolites against viral RdRp of SARS-CoV-2 and HCV. J. Mol. Liq. 390, 123153 (2023).","journal-title":"J. Mol. Liq."},{"key":"44924_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41580-021-00432-z","volume":"23","author":"B Malone","year":"2022","unstructured":"Malone, B., Urakova, N., Snijder, E. J. & Campbell, E. A. Structures and functions of coronavirus replication\u2013transcription complexes and their relevance for SARS-CoV-2 drug design. Nat. Rev. Mol. Cell Biol. 23, 21\u201339 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"44924_CR16","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/S0022-2836(02)01439-0","volume":"326","author":"D O'Farrell","year":"2003","unstructured":"O\u2019Farrell, D., Trowbridge, R., Rowlands, D. & J\u00e4ger, J. Substrate complexes of Hepatitis C virus RNA polymerase (HC-J4): Structural evidence for nucleotide import and de-novo initiation. J. Mol. Biol. 326, 1025\u20131035 (2003).","journal-title":"J. Mol. Biol."},{"key":"44924_CR17","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jmb.2008.10.071","volume":"385","author":"SG Sarafianos","year":"2009","unstructured":"Sarafianos, S. G. et al. Structure and function of HIV-1 reverse transcriptase: Molecular mechanisms of polymerization and inhibition. J. Mol. Biol. 385, 693\u2013713 (2009).","journal-title":"J. Mol. Biol."},{"key":"44924_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101992","author":"AK Padhi","year":"2021","unstructured":"Padhi, A. K., Shukla, R., Saudagar, P. & Tripathi, T. High-throughput rational design of the remdesivir binding site in the RdRp of SARS-CoV-2: Implications for potential resistance. Iscience https:\/\/doi.org\/10.1016\/j.isci.2020.101992 (2021).","journal-title":"Iscience"},{"key":"44924_CR19","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","volume":"383","author":"JH Beigel","year":"2020","unstructured":"Beigel, J. H. et al. Remdesivir for the treatment of Covid-19. N. Engl. J. Med. 383, 1813\u20131826 (2020).","journal-title":"N. Engl. J. Med."},{"key":"44924_CR20","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa2116044","volume":"386","author":"A Jayk Bernal","year":"2022","unstructured":"Jayk Bernal, A. et al. Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients. N. Engl. J. Med. 386, 509\u2013520 (2022).","journal-title":"N. Engl. J. Med."},{"key":"44924_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s44259-025-00125-z","volume":"3","author":"DZH Aw","year":"2025","unstructured":"Aw, D. Z. H., Zhang, D. X. & Vignuzzi, M. Strategies and efforts in circumventing the emergence of antiviral resistance against conventional antivirals. npj Antimicrob. Resist. 3, 54 (2025).","journal-title":"npj Antimicrob. Resist."},{"key":"44924_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ph17050661","volume":"17","author":"D Palazzotti","year":"2024","unstructured":"Palazzotti, D. et al. Small molecule drugs targeting viral polymerases. Pharmaceuticals 17, 661 (2024).","journal-title":"Pharmaceuticals"},{"key":"44924_CR23","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","volume":"55","author":"T Sterling","year":"2015","unstructured":"Sterling, T. & Irwin, J. J. ZINC 15 \u2013 Ligand discovery for everyone. J. Chem. Inf. Model. 55, 2324\u20132337 (2015).","journal-title":"J. Chem. Inf. Model."},{"key":"44924_CR24","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1093\/bioinformatics\/btx491","volume":"33","author":"D Lagorce","year":"2017","unstructured":"Lagorce, D., Bouslama, L., Becot, J., Miteva, M. A. & Villoutreix, B. O. FAF-Drugs4: Free ADME-tox filtering computations for chemical biology and early stages drug discovery. Bioinformatics 33, 3658\u20133660 (2017).","journal-title":"Bioinformatics"},{"key":"44924_CR25","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2018.00007","volume":"6","author":"P Mathur","year":"2018","unstructured":"Mathur, P., Kottilil, S. & Wilson, E. Use of ribavirin for Hepatitis C treatment in the modern direct-acting antiviral era. J. Clin. Transl. Hepatol. 6, 431 (2018).","journal-title":"J. Clin. Transl. Hepatol."},{"key":"44924_CR26","doi-asserted-by":"publisher","first-page":"6851","DOI":"10.3390\/cimb45080433","volume":"45","author":"PN Kamzeeva","year":"2023","unstructured":"Kamzeeva, P. N., Aralov, A. V., Alferova, V. A. & Korshun, V. A. Recent advances in molecular mechanisms of nucleoside antivirals. Curr. Issues Mol. Biol. 45, 6851\u20136879 (2023).","journal-title":"Curr. Issues Mol. Biol."},{"key":"44924_CR27","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.fitote.2014.10.011","volume":"99","author":"TS Wahyuni","year":"2014","unstructured":"Wahyuni, T. S. et al. Inhibition of hepatitis C virus replication by chalepin and pseudane IX isolated from Ruta angustifolia leaves. Fitoterapia 99, 276\u2013283 (2014).","journal-title":"Fitoterapia"},{"key":"44924_CR28","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1128\/AAC.44.4.859-866.2000","volume":"44","author":"W Markland","year":"2000","unstructured":"Markland, W., McQuaid, T., Jain, J. & Kwong, A. Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: A comparison with ribavirin and demonstration of antiviral additivity with alpha interferon. Antimicrob. Agents Chemother. 44, 859\u2013866 (2000).","journal-title":"Antimicrob. Agents Chemother."},{"key":"44924_CR29","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0026-895X(25)09567-7","volume":"38","author":"R Fernandez-Larsson","year":"1990","unstructured":"Fernandez-Larsson, R. & Patterson, J. L. Ribavirin is an inhibitor of Human Immunodeficiency Virus reverse transcriptase. Mol. Pharmacol. 38, 766\u2013770 (1990).","journal-title":"Mol. Pharmacol."},{"key":"44924_CR30","doi-asserted-by":"publisher","first-page":"W320","DOI":"10.1093\/nar\/gku316","volume":"42","author":"X Robert","year":"2014","unstructured":"Robert, X. & Gouet, P. Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res. 42, W320\u2013W324 (2014).","journal-title":"Nucleic Acids Res."},{"key":"44924_CR31","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2014A visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"44924_CR32","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"D Van Der Spoel","year":"2005","unstructured":"Van Der Spoel, D. et al. GROMACS: fast, flexible, and free. J. Comput. Chem. 26, 1701\u20131718 (2005).","journal-title":"J. Comput. Chem."},{"key":"44924_CR33","first-page":"455","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Chem. Inf. Model. 31, 455\u2013461 (2010).","journal-title":"J. Chem. Inf. Model."},{"key":"44924_CR34","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/protein\/8.2.127","volume":"8","author":"AC Wallace","year":"1995","unstructured":"Wallace, A. C., Laskowski, R. A. & Thornton, J. M. LIGPLOT: A program to generate schematic diagrams of protein-ligand interactions. Protein Eng. Des. Sel. 8, 127\u2013134 (1995).","journal-title":"Protein Eng. Des. Sel."},{"key":"44924_CR35","doi-asserted-by":"publisher","first-page":"7643","DOI":"10.1016\/j.matpr.2021.03.114","volume":"45","author":"A Khaldan","year":"2021","unstructured":"Khaldan, A. et al. 3D-QSAR modeling, molecular docking and ADMET properties of benzothiazole derivatives as \u03b1-glucosidase inhibitors. Mater. Today Proc. 45, 7643\u20137652 (2021).","journal-title":"Mater. Today Proc."},{"key":"44924_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2021.131190","volume":"1246","author":"PR Nagar","year":"2021","unstructured":"Nagar, P. R., Gajjar, N. D. & Dhameliya, T. M. In search of SARS CoV-2 replication inhibitors: Virtual screening, molecular dynamics simulations and ADMET analysis. J. Mol. Struct. 1246, 131190 (2021).","journal-title":"J. Mol. Struct."},{"key":"44924_CR37","doi-asserted-by":"publisher","first-page":"W257","DOI":"10.1093\/nar\/gky318","volume":"46","author":"P Banerjee","year":"2018","unstructured":"Banerjee, P., Eckert, A. O., Schrey, A. K. & Preissner, R. ProTox-II: A webserver for the prediction of toxicity of chemicals. Nucleic Acids Res. 46, W257\u2013W263 (2018).","journal-title":"Nucleic Acids Res."},{"key":"44924_CR38","doi-asserted-by":"publisher","first-page":"6474","DOI":"10.1021\/jp003919d","volume":"105","author":"GA Kaminski","year":"2001","unstructured":"Kaminski, G. A., Friesner, R. A., Tirado-Rives, J. & Jorgensen, W. L. Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides. J. Phys. Chem. B 105, 6474\u20136487 (2001).","journal-title":"J. Phys. Chem. B"},{"key":"44924_CR39","doi-asserted-by":"publisher","first-page":"W331","DOI":"10.1093\/nar\/gkx312","volume":"45","author":"LS Dodda","year":"2017","unstructured":"Dodda, L. S., Cabeza de Vaca, I., Tirado-Rives, J. & Jorgensen, W. L. LigParGen web server: An automatic OPLS-AA parameter generator for organic ligands. Nucleic Acids Res. 45, W331\u2013W336 (2017).","journal-title":"Nucleic Acids Res."},{"key":"44924_CR40","doi-asserted-by":"crossref","unstructured":"Hirshman, S. P. & Whitson, J. Steepest descent moment method for three-dimensional magnetohydrodynamic equilibria. (Oak Ridge National Lab.(ORNL), Oak Ridge, TN (United States), 1983).","DOI":"10.2172\/5537804"},{"key":"44924_CR41","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","volume":"18","author":"B Hess","year":"1997","unstructured":"Hess, B., Bekker, H., Berendsen, H. J. & Fraaije, J. G. LINCS: A linear constraint solver for molecular simulations. J. Comput. Chem. 18, 1463\u20131472 (1997).","journal-title":"J. Comput. Chem."},{"key":"44924_CR42","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/08927028808080941","volume":"1","author":"WF Van Gunsteren","year":"1988","unstructured":"Van Gunsteren, W. F. & Berendsen, H. J. A leap-frog algorithm for stochastic dynamics. Mol. Simul. 1, 173\u2013185 (1988).","journal-title":"Mol. Simul."},{"key":"44924_CR43","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden, S. & Ryde, U. The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin. Drug Discov. 10, 449\u2013461 (2015).","journal-title":"Expert Opin. Drug Discov."},{"key":"44924_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.arabjc.2021.103057","volume":"14","author":"M Aarjane","year":"2021","unstructured":"Aarjane, M., Slassi, S., Ghaleb, A., Tazi, B. & Amine, A. Synthesis, biological evaluation, molecular docking and in silico ADMET screening studies of novel isoxazoline derivatives from acridone. Arab. J. Chem. 14, 103057 (2021).","journal-title":"Arab. J. Chem."},{"key":"44924_CR45","doi-asserted-by":"publisher","first-page":"9696","DOI":"10.1074\/jbc.RA118.002588","volume":"293","author":"H Freedman","year":"2018","unstructured":"Freedman, H., Winter, P., Tuszynski, J., Tyrrell, D. L. & Houghton, M. A computational approach for predicting off-target toxicity of antiviral ribonucleoside analogues to mitochondrial RNA polymerase. J. Biol. Chem. 293, 9696\u20139705 (2018).","journal-title":"J. Biol. Chem."},{"key":"44924_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2021.775226","volume":"9","author":"H-J Yu","year":"2021","unstructured":"Yu, H.-J., Xiao, G.-L., Zhao, Y.-Y., Wang, X.-X. & Lan, R. Targeting mitochondrial metabolism and RNA polymerase POLRMT to overcome multidrug resistance in cancer. Front. Chem. 9, 775226 (2021).","journal-title":"Front. Chem."},{"key":"44924_CR47","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1080\/14786419.2022.2092865","volume":"37","author":"A Zarei","year":"2023","unstructured":"Zarei, A., Ramazani, A., Rezaei, A. & Moradi, S. Screening of honey bee pollen constituents against COVID-19: An emerging hot spot in targeting SARS-CoV-2-ACE-2 interaction. Nat. Prod. Res. 37, 974\u2013980 (2023).","journal-title":"Nat. Prod. Res."},{"key":"44924_CR48","unstructured":"Amirkhani, R., Zarei, A., Gholampour, M., Tavakoli, H. & Ramazani, A. Honey and royal jelly natural products as possible antiviral nominations to combat SARS-CoV-2 main protease. ECC, 567\u2013579, (2022)."},{"key":"44924_CR49","doi-asserted-by":"crossref","unstructured":"Shamsian, S., Sokouti, B. & Dastmalchi, S. Benchmarking different docking protocols for predicting the binding poses of ligands complexed with cyclooxygenase enzymes and screening chemical libraries. 14, 29955, (2024)","DOI":"10.34172\/bi.2023.29955"},{"key":"44924_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117592","volume":"253","author":"AA Elfiky","year":"2020","unstructured":"Elfiky, A. A. Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study. Life Sci. 253, 117592 (2020).","journal-title":"Life Sci."},{"key":"44924_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2021.104613","volume":"135","author":"KS Ebrahimi","year":"2021","unstructured":"Ebrahimi, K. S. et al. In silico investigation on the inhibitory effect of fungal secondary metabolites on RNA dependent RNA polymerase of SARS-CoV-II: A docking and molecular dynamic simulation study. Comput. Biol. Med. 135, 104613 (2021).","journal-title":"Comput. Biol. Med."},{"key":"44924_CR52","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1093\/bib\/bbaa378","volume":"22","author":"CB Mishra","year":"2021","unstructured":"Mishra, C. B. et al. Identifying the natural polyphenol catechin as a multi-targeted agent against SARS-CoV-2 for the plausible therapy of COVID-19: an integrated computational approach. Brief. Bioinform. 22, 1346\u20131360 (2021).","journal-title":"Brief. Bioinform."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44924-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44924-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44924-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T12:02:50Z","timestamp":1785931370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44924-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["44924"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-44924-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"28 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"24076"}}